In computer-aided drug development, the identification of potential hits in silico, which uses high-throughput molecular docking, has grown in popularity. In silico simulations give researchers the chance to consider various study designs, thereby lowering the level of uncertainty surrounding the results and enabling a quicker and more effective drug development process. We have a team of bioinformatics specialists to aid in interpreting your in silico data in an elegant and simple manner and help you with the publication.